Endothelial Cell Loss and Induced Astigmatism After Wound-directed and Wound-assisted IOL Injection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if there is any difference in astigmatism (eye surface curvature) or corneal endothelial cell density (the inner cell lining of the eye surface) after two different methods for inserting a lens during cataract surgery.
| Condition | Intervention |
|---|---|
|
Cataracts Cataract Surgery |
Procedure: Lens insertion during cataract surgery |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Endothelial Cell Loss and Surgically Induced Astigmatism After 2.2 mm Wound Assisted vs 2.4 mm Wound-Directed Clear Corneal Incisions for Intraocular Lens Insertion During Cataract Surgery |
- Surgically induced astigmatism [ Time Frame: 1 month ] [ Designated as safety issue: No ]measured by topography at 1 month post operative visit
- Endothelial cell loss [ Time Frame: one month ] [ Designated as safety issue: No ]As measured by specular microscopy
- Best corrected visual acuity [ Time Frame: one month ] [ Designated as safety issue: No ]By manifest refraction
- Final incision size [ Time Frame: intraoperatively (day #0) ] [ Designated as safety issue: No ]measured with incision gauges before and after lens injection.
| Enrollment: | 72 |
| Study Start Date: | April 2010 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Wound-assisted lens injection
Wound-assisted lens injection is considered neither superior or inferior to wound-directed lens injection.
|
Procedure: Lens insertion during cataract surgery
After cataract removal during cataract surgery, a lens needs to be injected into the eye. Both arms are routinely used but different methods for injecting the lens.
|
|
Active Comparator: Wound-directed lens injection
Wound-directed lens injection is neither considered superior nor inferior to wound-assisted lens injection.
|
Procedure: Lens insertion during cataract surgery
After cataract removal during cataract surgery, a lens needs to be injected into the eye. Both arms are routinely used but different methods for injecting the lens.
|
Detailed Description:
Cataract surgery (removal of a cloudy lens) is currently performed through increasingly smaller incisions. Bimanual surgery, where two instruments are used to remove the lens, is performed through two 1.4 mm incisions. Typically, one of these incisions is enlarged to 2.2 or 2.4 mm in order that the IOL (artificial lens) can be inserted into the eye. Surgeons insert these lenses by placing a lens injector cartridge completely into the eye (wound-directed insertion) or by placing only the tip inside the incision (wound-assisted insertion). While wound-assisted insertion can be performed through slightly smaller incisions (2.2 mm versus 2.4 mm for wound-directed insertion), both methods of insertion cause some incision enlargement. There is some evidence that wound-assisted insertion can cause very short-term pressure within the eye to go up. Neither method is considered inferior or superior to the other, and the primary investigator (Dr. Kenneth Cohen) routinely uses both methods.
No studies have directly compared wound-healing characteristics between these two methods. We seek to compare differences in:
- Surgically-induced astigmatism (changes in the corneal curvature from cataract surgery incisions.
- Endothelial cell density loss. Endothelial cells line the inside surface of the cornea, and their overall density can be decreased by cataract surgery.
- Best-corrected vision after surgery
- Sizes of the incisions after lens injection
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Eligible patients include those who undergo uncomplicated cataract extraction surgery and IOL implantation by KLC.
Exclusion Criteria: Patients who:
- suffer from diabetes and have more than mild background diabetic retinopathy,
- have a history of intraocular surgery,
- have a history of ocular trauma,
- have known pathology of the cornea,
- have a history of intraocular inflammation,
- are unable to understand English,
- are decisionally impaired,
- are currently incarcerated, or
- are less than 18 years of age.
No exclusions will be made on the basis of gender, ethnicity, or race.
Contacts and Locations| United States, North Carolina | |
| Kittner Eye Center | |
| Chapel Hill, North Carolina, United States, 27599 | |
| Principal Investigator: | Kenneth Cohen, MD | UNC dept. of ophthalmology |
More Information
Publications:
| Responsible Party: | Dr. Kenneth Cohen, Dept. of Ophthalmology, UNC Chapel Hill |
| ClinicalTrials.gov Identifier: | NCT01250964 History of Changes |
| Other Study ID Numbers: | 10-0435 |
| Study First Received: | November 29, 2010 |
| Last Updated: | November 30, 2010 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Astigmatism Cataract Refractive Errors Eye Diseases Lens Diseases |
ClinicalTrials.gov processed this record on June 18, 2013